Compare PTCT & ENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTCT | ENS |
|---|---|---|
| Founded | 1998 | 1991 |
| Country | United States | United States |
| Employees | N/A | 9200 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 6.0B |
| IPO Year | 2006 | 2004 |
| Metric | PTCT | ENS |
|---|---|---|
| Price | $66.77 | $161.84 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 3 |
| Target Price | $80.94 | ★ $193.00 |
| AVG Volume (30 Days) | ★ 1.0M | 373.9K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.65% |
| EPS Growth | ★ 264.48 | 38.31 |
| EPS | ★ 7.78 | 5.65 |
| Revenue | ★ $264,734,000.00 | $216,125,000.00 |
| Revenue This Year | N/A | $4.63 |
| Revenue Next Year | $21.65 | $3.46 |
| P/E Ratio | ★ $8.29 | $28.47 |
| Revenue Growth | ★ 36.19 | 15.85 |
| 52 Week Low | $35.95 | $76.57 |
| 52 Week High | $87.50 | $194.77 |
| Indicator | PTCT | ENS |
|---|---|---|
| Relative Strength Index (RSI) | 46.23 | 44.63 |
| Support Level | $61.43 | $157.23 |
| Resistance Level | $68.44 | $184.13 |
| Average True Range (ATR) | 2.62 | 5.64 |
| MACD | 0.19 | -0.73 |
| Stochastic Oscillator | 55.17 | 43.07 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
EnerSys provides stored energy solutions for industrial applications. It also manufactures and distributes energy systems solutions and motive power batteries, specialty batteries, battery chargers, power equipment, battery accessories, and outdoor equipment enclosure solutions to customers. Energy Systems that combine enclosures, power conversion, power distribution, and energy storage are used in the telecommunication and broadband, utility industries, uninterruptible power supplies, and numerous applications requiring stored energy solutions. Its segments include Energy Systems, Motive Power, and Specialty.